"Boron Compounds" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Inorganic or organic compounds that contain boron as an integral part of the molecule.
Descriptor ID |
D001896
|
MeSH Number(s) |
D01.132 D02.203
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Boron Compounds".
Below are MeSH descriptors whose meaning is more specific than "Boron Compounds".
This graph shows the total number of publications written about "Boron Compounds" by people in this website by year, and whether "Boron Compounds" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 0 | 1 | 1 |
1999 | 1 | 0 | 1 |
2008 | 0 | 1 | 1 |
2012 | 0 | 1 | 1 |
2022 | 1 | 0 | 1 |
2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Boron Compounds" by people in Profiles.
-
Next-Generation Boron Drugs and Rational Translational Studies Driving the Revival of BNCT. Cells. 2023 05 16; 12(10).
-
Design and evaluation of novel analogs of 2-amino-4-boronobutanoic acid (ABBA) as inhibitors of human gamma-glutamyl transpeptidase. Bioorg Med Chem. 2022 11 01; 73:116986.
-
Fluorescence-on response via CB7 binding to viologen-dye pseudorotaxanes. Org Lett. 2012 Aug 17; 14(16):4046-9.
-
Isolation and in vitro binding of mating type plus fertilization tubules from Chlamydomonas. Methods Mol Biol. 2008; 475:213-22.
-
Pharmacokinetics of 10B-p-boronophenylalanine in tumours, skin and blood of melanoma patients: a study of boron neutron capture therapy for malignant melanoma. Melanoma Res. 1999 Feb; 9(1):75-83.
-
Human melanoma treated by boron neutron capture therapy: comparison of the clinical response with the predicted response. Radiat Med. 1996 Sep-Oct; 14(5):257-63.
-
[Neutron capture therapy for cancer]. Gan To Kagaku Ryoho. 1994 Feb; 21(3):374-8.
-
Improved bioavailability of para-boronophenylalanine by cyclodextrin complexation. J Pharm Sci. 1993 Oct; 82(10):1054-7.
-
Tissue distribution of para-boronophenylalanine administered orally as a cyclodextrin inclusion complex to melanoma-bearing hamsters. Pigment Cell Res. 1992 Feb; 5(1):38-40.
-
The relative biological effectiveness of 10B-neutron capture therapy for early skin reaction in the hamster. Radiat Res. 1991 Nov; 128(2):186-91.